Cost-Effectiveness of Intralesional Injection of Recombinant Human Epidermal Growth Factor for the Treatment of Severe Diabetic Foot Ulcers in Russian Health Care Setting
Nov 1, 2013, 00:00
10.1016/j.jval.2013.08.672
https://www.valueinhealthjournal.com/article/S1098-3015(13)02577-1/fulltext
Title :
Cost-Effectiveness of Intralesional Injection of Recombinant Human Epidermal Growth Factor for the Treatment of Severe Diabetic Foot Ulcers in Russian Health Care Setting
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)02577-1&doi=10.1016/j.jval.2013.08.672
First page :
A440
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
651